Flavio Ribichini

Showing 1-17 of 17 articles

Author Gabor Toth

Coronary interventions

Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial

Toth G, De Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, Van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E

December 6, 2019 | 10.4244/EIJ-D-19-00463

Author Francesco Saia

Interventions for valvular disease

Sapien 3 Ultra balloon-expandable transcatheter aortic valve: in-hospital and 30-day results from the multicentre S3U registry

Saia F, Gandolfo C, Palmerini T, Berti S, Doshi SN, Laine M, Marcelli C, Piva T, Ribichini F, De Benedictis M, Cardaioli F, Cannata S, Tarantini G

November 26, 2019 | 10.4244/EIJ-D-19-00541

Author Michele Pighi

NVT ALLEGRA transcatheter heart valve for valve-in-valve procedures in failing surgical aortic bioprostheses: let us wait and see

Pighi M, Lunardi M, Ribichini F

October 4, 2019 | 10.4244/EIJV15I9A137

Author Gabor Toth

Coronary interventions

Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting. The GRAFFITI trial

Toth G, De Bruyne B, Kala P, Ribichini F, Casselman F, Ramos R, Piroth Z, Fournier S, Piccoli A, Van Mieghem C, Penicka M, Mates M, Nemec P, Van Praet F, Stockman B, Degriek I, Barbato E

July 2, 2019 | 10.4244/EIJ-D-19-00463

Author Flavio Ribichini

The promise of vascular reparative therapy in standby mode. How long before a final decision? Complete vessel wall regeneration and vascular scaffold resorption after left anterior descending reconstructions

Ribichini F, Pesarini G

July 20, 2018 | 10.4244/EIJV14I4A65

Author Roberto Scarsini

Physiologic evaluation of coronary lesions using instantaneous wave-free ratio (iFR) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation

Scarsini R, Pesarini G, Zivelonghi C, Piccoli A, Ferrero V, Lunardi M, Gottin L, Zanetti C, Faggian G, Ribichini F

January 19, 2018 | 10.4244/EIJ-D-17-00542

Author Fabrizio D’ascenzo

Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI

D’ascenzo F, Benedetto U, Bianco M, Conrotto F, Moretti C, D’Onofrio A, Agrifoglio M, Colombo A, Ribichini F, Tarantini G, D’Amico M, Salizzoni S, Rinaldi M

December 8, 2017 | 10.4244/EIJ-D-17-00198

Author Luca Testa

Coronary interventions

One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)

Testa L, De Carlo M, Petrolini A, Rapetto C, Varbella F, Cortese B, Gabrielli G, Geraci S, Loi B, Boccuzzi G, Tarantini G, Fischetti D, Calabria P, Tomai F, Ribichini F, Tamburino C, Indolfi C, Bartorelli A, Petronio A, Bedogni F

July 20, 2017 | 10.4244/EIJ-D-17-00246

Author Emanuele Barbato

European expert consensus on rotational atherectomy

Barbato E, Carrié D, Dardas P, Fajadet J, Gaul G, Haude M, Khashaba A, Koch K, Meyer-Gessner M, Palazuelos J, Reczuch K, Ribichini F, Sharma SK, Sipotz J, Sjögren I, Suetsch G, Szabo G, Valdés Chávarri M, Vaquerizo B, Wijns W, Windecker S, De Belder A

May 19, 2015 | 10.4244/EIJV11I1A6

Author Flavio Ribichini

The need for this supplement: beyond “exercises in style”

Ribichini F, Cuisset T

August 19, 2014 | 10.4244/EIJV10STA1

Author Roberto Diletti

Percutaneous coronary interventions during ST-segment elevation myocardial infarction: current status and future perspectives

Diletti R, Yetgin T, Manintveld O, Ligthart J, Zivelonghi C, Zijlstra F, Ribichini F

August 19, 2014 | 10.4244/EIJV10STA4

Author Flavio Ribichini

Numbers needed to treat (lives!) and numbers needed to save (money)

Ribichini F, Taggart D, Vassanelli C

June 28, 2013 | 10.4244/EIJV9I2A28

Author Flavio Ribichini

Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS)

Ribichini F, Tomai F, Reimers B, Russo P, Borioni R, SpartÃ D, Pacchioni A, Pesarini G, Spagnolo B, De Persio G, Cremonesi A, Castriota F

August 15, 2010

Author Flavio Ribichini

The gap between vascular interventions and vascular medicine

Ribichini F, Tomai F, Castriota F, Russo P, Reimers B

May 25, 2010

Author Valeria Ferrero

Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levels

Ferrero V, Tomai F, Versaci F, Feola M, Proietti I, Rognoni A, Ghini A, Gaspardone A, Vacca G, De Luca L, Vassanelli C, Ribichini F

June 30, 2009

Author Pierfrancesco Agostoni

On the current epidemic outburst of meta-analytic rage in interventional cardiology

Agostoni P, Ribichini F, Wijns W

May 19, 2009

Author Flavio Ribichini

Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD study

Ribichini F, Tomai F, Ferrero V, Versaci F, Boccuzzi G, Proietti I, Prati F, Crea F, Vassanelli C

August 20, 2005

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more

December 3, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: DYNAMIC Trial, S3U registry and much more

November 26, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke